This study investigates advanced solid tumors. The purpose of this study is to evaluate an investigational medication known as MRG007.
The study focuses on understanding the safety and tolerability of MRG007. It evaluates how the body processes the medication and its effects on the tumors.
- Who can participate: Adults with advanced or metastatic solid tumors without standard treatment options and a life expectancy of at least 3 months may participate.
- Study details: Participants will receive the investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.